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Conclusion: Because molecular typing makes it possible to track the
dissemination of specific clones, it may facilitate the breaking down of
endemic transmission to the level of micro-epidemics.
IMoG2-311s multi-resistance an indicator of higher
transmissibility of nosocomial pathogens?
M. J. Struelens
Universite Libre de Bruxel/es, Hopital Erasme, Brussels, Belgium
A large number of molecular epidemiologic studies document the epidemic
spread of antibiotic-resistant clones of nosocomial pathogens within and
between hospitals. The pressure of intense antibiotic use in the hospital
patient population confers a selective advantage to resistant clones which are
more likely to survive and multiply to replace the antibiotic susceptible
commensal tlora. Examples ofepidemic antibiotic resistant clones associated
with large scale epidemics which can lead to a net excess of nosocomial
infection by that species include methicillin-resistant Staphylococcus aureus,
clindamycin-resistant Clostridium dijJicile, multi-drug resistant A&inetobacter
baumannii. Klebsiella pneumoniae. Enterobacter aerogenes and Burkholderia
cepacia. Less information is available regarding the hypothesis that successful
antibiotic resistant clones carry additional virulence determinants enhancing
their transmissibility and/or pathogenicity. This type ofassociation has been
found among epidemic types of Klebsiella pneumoniae, carrying large
plasmids encoding multi-drug resistance (extended spectrum beta-Iaeta-
mase, aminoglycoside modifying enzymes) aerobaerin and an adhesin
promoting colonization of intestinal epithelium. Likewise, a pandemic
electrophoretype 12 of Burkholderia cepacia associated with nosocomial
outbreaks in cystic fibrosis patients harbours a specific gene coding for the
cblA pilin subunit and a conserved IS element which may promote genomic
rearrangements involved in resistance or transmissibility. Whereas multi-
resistance is often an indicator of epidemicity for nosocomial pathogens,
more studies are needed to determine genetic and functional determinants of
enhanced transmissibility ofepidemic clones beyond the seleerive advantage
of resistance. Identification of such markers would be useful to predier the
epidemic potential ofclinical isolates and respond accordingly with infection
control measures.
IMoG2-SI What tools do we need to understand the
dynamics of hospital acquired infections in places like intensive
care units?
H:ajo Grund.tna.nn
Noltingham. United Kingdom University
Molecular typing provides infection control personnel with a wealth ofdata
pertaining to the population structure ofthe pathogens that are isolated from
patients. Since hospital epidemiologists are conventionally more interested
in the population of hosts than in that of the pathogens routine typing data
are usually not exploited to their fuJI potential. Using this data for the
analysis of time space interaction by genotype may lead to the identification
of miniclusters that occur above a certain level of expeerancy. A couple of
statistical tests can be employed to that end. Another way ofutilising typing
data introduces differential risk faeror analysis which may include some
classical case control or cohort approaches. In typically endemic situations i.e
in the absence of outbreaks, hidden transmission dynamics may thus be
revealed and the success ofpreventive measures may be predicted by simple
stochastic models.
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IMoG3-11 Diagnosis and prevention of surgical site infections:
Problems with definitions
R. C. Spencer
Public Health Laboratory, Bristol BS2 8HW. United Kingdom
Surveillance studies require careful planning with a clear protocol, but,
above all, they need accepted definitions. No single set ofdefinitions has been
universally adopted, although there is a generally agreed-upon group of
ideas or problems central to the issue. A variety ofdefinitions ofnosocomial
infections have been proposed and used in hospital surveiJlance studies. Some
reports have proposed very simple definitions, while others have produced
much more detailed ones. Even when epidemiologists, nurses and clinical
microbiologists have produced consensus definitions, some health-care
workers stiJl find problems in their interpretation. There is no doubting
that variations in defmitions can influence the recorded rate ofinfection and
without definitive definitions, comparisons between hospitals are mean-
ingless. Unfortunately many individual institutions modify these consensus
definitions to suit their own particular resident populations and doctor/
laboratory facilities and availability. Indeed, some authors recommend that
this should happen. Whichever defmitions are used, microbiological and
imaging findings should be used only to confirm clinical evidence of
infection. It is strongly recommended that aJl professional as.sociations of
those health-eare workers involved in the surveillance of nosocomial
infections should co-operate to develop standardised case definitions suitable
for routine use. A plea is made for simplicity and clarity. It remains essential
that such case defmitions for surveillance purposes ensure a high level of
sensitivity in order to allow the earliest detection of infective nosocomial
problems.
IMoG3-21 Nosocomial aspergillosis: Are there effective
measures for prevention
Patricia Munoz
Hospilal Gtneral Universilario "Gregorio Marmion". Madrid, Spain
Aspergillosis is the second most common nosocomial mycosis. Recommen-
dations to prevent aspergillosis in high-risk patients include the reduction of
environmental exposure and the recognition of predisposing faerors and
periods ofincreased risk The strict observation ofinfection control measures
(air quality, isolation of construction works) in centers with immunocom-
promised patients is essential. Environmental protection trying to insure that
the air of selected units is free from Aspergillus spores is the most important
step of prophylaxis, although it is not always possible. Constant environ-
mental surveillance is a difficult goal and exposure may occur at other sites of
the hospital or in the community. The prompt recognition ofnosocomia1
cases is also recommended. The reduction of predisposing factors in high-
risk patients may include the prevention and adequate management of
neutropenia and rejection episodes, the prevention of infections such as
CMV. HHV-6 or relapsing HCV and the judicious use of Immuno
suppressive therapy. Targeted surveillance cultures and primary prophylaxis
against invasive aspergillosis are not standard measures in solid organ
transplant recipients although they are more commouly used for neutro-
penic patients. The current lack of reliable preventive regimens against
aspergillosis and against emerging resistant fungal pathogens presents an
ongoing challenge. New antifungal agents, such as triazoles and new AMB
presentations. have proved to be u..,ful in some recent studies.
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IMoG4-1 [ Non-invasive tests for the diagnosis of Hellcobacter
pylori infection
H. Rautelin
Department ofBacteriology and Immunology, Haartman Institute, University of
Helsinki, and Helsinki U"iversity Central Hospital Laboratory Diagnostics,
Helsinki, Finland
Non-invasive (gastroscopy not needed) diagnosis of H. pylori infection
includes in practice detection of H. pylori antibodies, urea breath tests, and
a recently developed test detecting H. pylori antigen in stool. In the primary
diagnosis of H. pylori infection, non-invasive diagnostic methods may be
used solely in younger patients who are not endoscopied. Among patients
endoscopied, non-invasive diagnostic methods are useful in addition to
invasive tests. For instance in atrophic gastritis, invasive diagnostic methods,
and even urea breath test, may fail in showing H. pylori probably due to the
low number of bacteria present. However, elevated antibody titres of H.
pylori may still indicate the infection in these cases. In general, no single test is
optimal in the diagnosis of H. pylori infection but the best test(s) in each
clinical setting may be chosen if the advantages and restrictions of the
different tests are known. AJI diagnostic tests should be validated locaJly. As
the prevalence of H. pylori infection is rapidly decreasing in developed
coumries, the positive predictive value of the test might be very different
from that in a high prevalence population.
In contrast to biopsy-based tests, non-invasive diagnostic methods may
also be used for the foJlow-up oferadication therapy; urea breath test as early
as 4 weeks and quantitative serology 4-6 months after the therapy. If
serology is used for the foJlow-up, pre-treatmcm serum sample must be.
